You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

WARFARIN SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Warfarin Sodium patents expire, and when can generic versions of Warfarin Sodium launch?

Warfarin Sodium is a drug marketed by Amneal Pharms, Aurobindo Pharma Usa, Barr, Chartwell Rx, Invagen Pharms, Ipca Labs Ltd, Pliva, Taro, Usl Pharma, Watson Labs, and Zydus Pharms Usa. and is included in seventeen NDAs.

The generic ingredient in WARFARIN SODIUM is warfarin sodium. There are twenty-two drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the warfarin sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Warfarin Sodium

A generic version of WARFARIN SODIUM was approved as warfarin sodium by TARO on July 15th, 1999.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for WARFARIN SODIUM?
  • What are the global sales for WARFARIN SODIUM?
  • What is Average Wholesale Price for WARFARIN SODIUM?
Drug patent expirations by year for WARFARIN SODIUM
Drug Prices for WARFARIN SODIUM

See drug prices for WARFARIN SODIUM

Drug Sales Revenue Trends for WARFARIN SODIUM

See drug sales revenues for WARFARIN SODIUM

Recent Clinical Trials for WARFARIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AmgenEarly Phase 1
Boehringer IngelheimN/A
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1

See all WARFARIN SODIUM clinical trials

Pharmacology for WARFARIN SODIUM
Drug ClassVitamin K Antagonist
Mechanism of ActionVitamin K Inhibitors
Anatomical Therapeutic Chemical (ATC) Classes for WARFARIN SODIUM

US Patents and Regulatory Information for WARFARIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro WARFARIN SODIUM warfarin sodium TABLET;ORAL 040301-001 Jul 15, 1999 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Invagen Pharms WARFARIN SODIUM warfarin sodium TABLET;ORAL 090935-005 May 25, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Chartwell Rx WARFARIN SODIUM warfarin sodium TABLET;ORAL 040196-004 Sep 30, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms Usa WARFARIN SODIUM warfarin sodium TABLET;ORAL 040663-006 May 30, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ipca Labs Ltd WARFARIN SODIUM warfarin sodium TABLET;ORAL 200104-004 Jun 27, 2013 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Pliva WARFARIN SODIUM warfarin sodium TABLET;ORAL 040616-005 Jul 5, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.